Iambic Therapeutics, Inc. · NASDAQ:IAM

Iambic Therapeutics, Inc. insider trades

Iambic Therapeutics, Inc.'s insiders made 1 buy and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Oct 16, 2026Rachlin Evan LockwoodBuy718,750US$16.00Form 4

Iambic Therapeutics, Inc. shareholders